Past events

We're delighted to be attending the Annual Meeting of the GTA; Current Regulatory and Scientific Issues in Genetic Toxicology.

We are delighted to bring you our 2022 webinar: An Introduction to Nitrite in Excipient Testing to Accelerate Route Cause Investigation of Nitrosamines.

SmartTox, Lhasa Limited and BioActing discussed QSAR requirements for countries across the globe.

In this webinar, Lhasa Principal Application Scientists, Fernanda Waechter and Diego Zulkiewicz Gomes demonstrated how ICH M7 risk assessments can be performed for impurities in an API.

Lhasa Senior Scientist, Dr. Martyn Chilton presented a talk at this event, titled 'Assessing the dermal sensitisation potency of extractables and leachables using existing data and in silico methods'.

Dr. Alex Cayley, Lhasa Principal Scientist, presented a platform presentation titled ‘Integration of AOPs and computational models in chemical safety assessment’ during this event.

A team from Lhasa attended the 2022 Society of Toxicology Annual Meeting, in San Diego, California, where we hosted three exhibitor-hosted sessions, presented a number of scientific posters and had a Lhasa booth within the exhibition hall. We enjoyed meeting many Lhasa members, colleagues, collaborators and friends in a face to face setting again. 

We were delighted to welcome Andrew Teasdale PhD and Muzaffar Khan PhD to present within our webinar; Controlling potentially mutagenic impurities - hear from industry experts!

In this webinar, Lhasa Principal Application Scientists, Fernanda Waechter and Diego Zulkiewicz Gomes demonstrated how ICH M7 risk assessments can be performed for impurities in an API.

Dr. Reddy’s and Sindusfarma held a joint webinar which discussed Sartans - a new class of mutagenic impurities discovered in drugs commonly used to treat hypertension, heart and kidney diseases.